Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$14,266,002
+$126,371 QoQ
Shares Held
56,172
-2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#918
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Capital, LLC holds $139,654,335 across 9 Drug Manufacturers - General names. JNJ ranks #2 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
87,354 | $104,775,016 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
56,172 | $14,266,002 | |
| 3 | ABBV |
AbbVie Inc.
|
40,087 | $10,087,492 | |
| 4 | AMGN |
Amgen Inc
|
11,787 | $4,268,308 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,111 | $3,483,763 | |
| 6 | PFE |
Pfizer Inc
|
48,093 | $1,158,079 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,250 | $648,225 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,332 | $547,304 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,266,002 | 56,172 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $14,139,631 | 57,845 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $12,449,698 | 60,158 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $10,936,627 | 58,983 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $10,006,958 | 65,512 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $10,223,538 | 61,647 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $8,147,746 | 56,339 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $9,680,654 | 59,735 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $8,724,144 | 59,689 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $9,463,716 | 59,825 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $9,497,190 | 60,592 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $10,253,022 | 65,830 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $11,174,255 | 67,510 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $10,471,025 | 67,555 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $11,880,772 | 67,256 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,986,940 | 67,256 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $11,936,837 | 67,246 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $11,947,251 | 67,411 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $11,531,999 | 67,411 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $10,881,062 | 67,375 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $11,104,134 | 67,404 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $10,758,186 | 65,459 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $10,351,354 | 65,773 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $9,798,388 | 65,814 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $9,443,304 | 67,150 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $8,626,255 | 65,784 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||